Sign up to FoodBev and unlock more insights from the international food and beverage industry. Subscribers have access to webinars, newsletters, publications and more...
Weight-loss drugs: What happens to the food industry when appetite disappears?
Tom Ellis, CEO and co-owner at Brand Genetics, explains how the latest surge of weight-loss drugs is disrupting consumption and what’s next for producers.
Oikos Fusion launch: Exclusive interview with Rafael Acevedo, president of yogurt at Danone North America
FoodBev caught up with Rafael Acevedo, Danone’s president of yogurt, to find out more about the rising trends behind the brand's new 'first-of-its-kind' innovation.
GLP-1 alternative beverage aims to help consumers manage stress-related snacking
Ozzi, a new wellness brand based in the US, has introduced a natural drink designed to provide an alternative to GLP-1 medications, formulated to support evening appetite control.
Kate Farms unveils new high-protein shake to meet needs of GLP-1 medication users
Plant-based specialised nutrition brand Kate Farms has unveiled a new high-protein nutrition shake, designed to ‘nourish people in the midst of change,’ such as those using GLP-1 medications.
Research: UK study explores the role of food structure in digestion and health
A new UK study explores how the physical structure of food plays a key role in how the human body digests it, highlighting opportunities for manufacturers to develop foods with less adverse health effects.
IFF report highlights how GLP-1 drugs impact eating and drinking experience
A new report published by ingredient specialist IFF highlights how GLP-1 agonist drugs are ‘significantly’ impacting the nutritional needs and sensory eating experience of consumers.
Two Spoons debuts first high-protein ice cream with GLP-1-friendly ingredients
Two Spoons Creamery is launching its first high-protein ice cream with zero added sugar and GLP-1 compatibility in four flavours, Rocky Road, Strawberries & Cream, Caramel Swirl and Fudgy Brownie.
